论文部分内容阅读
长期以来654—2是治疗感染性休克、平滑肌痉挛性绞痛,脑血管痉挛、脑栓塞、牛皮癣等的有效药物。1998年11月到2000年4月我们根据654—2的解除内脏平滑肌痉挛作用及副作用小的特点,与乳糖酸红霉素联合静点,以减轻由红霉素所致的胃肠道不良反应,效果满意。现报告如下。1 临床资料与方法1.1 一般资料因近年红霉素的口服制剂多数已制成肠容型,对胃肠道不良反应较轻或无。因此本文63例均为红霉素静点过程中或静点完毕出现胃部不适如腹痛、恶心、呕吐,肠蠕动加快,肠鸣音抗进等消化道不良反应的患儿。随机分为
654-2 has long been a potent drug for the treatment of septic shock, smooth muscle spasmodic colic, cerebral vasospasm, cerebral embolism, psoriasis and the like. November 1998 to April 2000 we 654-2 according to the lifting of visceral smooth muscle spasm and side effects of small features, combined with erythromycin lactobionate intravenous point to reduce the gastrointestinal adverse reactions caused by erythromycin Satisfactory results. The report is as follows. 1 Clinical data and methods 1.1 General Information Because of the majority of oral formulations of erythromycin in recent years has made intestinal capacity, gastrointestinal adverse reactions were mild or no. Therefore, 63 cases of erythromycin in this article during the static point or the static point of completion of gastric discomfort such as abdominal pain, nausea, vomiting, intestinal peristalsis, bowel sounds resistant to enterogastric adverse reactions in children. Randomly divided into